Navigation Links
Study Shows Newer Antiepileptic Drugs and Mood Stabilizers May be Safer Choice during Pregnancy
Date:7/17/2017

In a newly published journal issue of Birth Defects Research: Depression and Its Treatments during Pregnancy, studies take a closer look at maternal depression, its effects and the effects of various treatments of the disease on a developing baby with one study showing newer medications may be safer choices.

The scientific journal released today (see the Overview, doi: 10.1002/bdr2.1080) includes articles covering the impact untreated maternal depression may have on a developing fetus, factors to consider if treating depression in a pregnant patient (DOI: 10.1002/bdr2.1074), the potential effects of antidepressant use during pregnancy on pregnancy outcomes such as birth defects (DOI: 10.1002/bdr2.1078), and neurobehavioral development of children who were exposed to antidepressants in utero (DOI: 10.1002/bdr2.1076). “Understanding how to effectively treat depression in pregnant women and minimize risk to the developing fetus is critical,” explained Kembra Howdeshell, PhD, Health Scientist at the National Institute of Environmental Health Sciences and co-editor of the special issue of Birth Defects Research. “Nearly 13% of women experience depression during pregnancy and the rates after delivery are even higher.”

While the issue includes studies reviewing selective serotonin reuptake inhibitor (SSRI) use during pregnancy, one article led by Asher Ornoy, MD, the special issue’s co-editor who is a physician and researcher at Hebrew University Hadassah Medical School in Jerusalem, focused on the outcomes of pregnant women who used non-SSRI medications to treat depression. In their contribution “Antidepressants, antipsychotics and mood stabilizers in pregnancy: what do we know and how should we treat pregnant women with depression,” Dr. Ornoy and colleagues found that specific non-SSRIs, tricyclic and tetracyclic drugs, appear to be safe, while some mood stabilizers, such as lithium, valproic acid, carbamazepine and topiramate lead to birth defects if used during pregnancy (DOI: 10.1002/bdr2.1079). “We did find that newer antiepileptic drugs and mood stabilizers, such as lamotrigine and levetiracetam, do not appear to cause higher rates of birth defects,” said Dr. Ornoy. “They also did not appear to cause higher rates of neurodevelopmental alterations which is very encouraging,” he added.

Other topics covered in the issue include the role of serotonin in early brain development (DOI: 10.1002/bdr2.1085) and how SSRIs might alter it leading to possible long-term effects, and a review of antidepressant use during breastfeeding (DOI: 10.1002/bdr2.1077) and how most psychotropic medications that reach an infant through breastmilk don’t appear to have any effect on the baby. It also includes an article describing the epigenetics of clinical depression (DOI: 10.1002/bdr2.1081) and how the monitoring of certain genes may help to identify these non-DNA-coding changes to gene expression that are associated with life-long behavioral alterations in offspring of women diagnosed with clinical depression during pregnancy.

“Researchers are making advances toward effectively treating the pregnant patient’s depression while trying to reduce possible effects of treatment on the baby,” commented Dr. Howdeshell. “More research is needed to better understand how maternal depression and its medical treatment during pregnancy and breastfeeding may or may not alter psychosocial outcomes of exposed infants.”    

About the Teratology Society

The Teratology Society, an international professional group of scientists hailed as the premier source for cutting-edge research and authoritative information related to birth defects and developmentally mediated disorders, publishes Birth Defects Research with John Wiley & Sons. The Teratology Society is made up of more than 700 members worldwide specializing in a variety of disciplines related to birth defects research, including developmental biology and toxicology, reproduction and endocrinology, epidemiology, cell and molecular biology, nutritional biochemistry, and genetics as well as the clinical disciplines of prenatal medicine, pediatrics, obstetrics, neonatology, medical genetics, and teratogen risk counseling. Scientists interested in membership in the Teratology Society are encouraged to visit http://www.teratology.org.

Additional Public Resources
For more information on depression and the known effects of its treatments during pregnancy and while breastfeeding, please visit MotherToBaby and the March of Dimes.

Media Contact: Nicole Chavez, 619-368-3259, nchavez(at)teratology.org.

Read the full story at http://www.prweb.com/releases/Birth_Defects_Research/Depression_2017/prweb14500401.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Author Florencia Chang-Ageda's Newly Released “Divine Revelations-Eye Openers” is A Study in the Many Ways that Scripture can Inspire those Who are Open to His Word
2. Local Marketing: Study Shows Alternatives to Pain Medications can be Effective
3. Arlington, VA Dentist, Dr. Duke Kim, Attends Spear® Study Club, Offers Skilled Dental Implant Solutions
4. Orange County Dentist, Dr. A. Rassouli, Comments on the Study on How Increased Weight Could Affect Dental Risk
5. Canadian Zeolite Announces Positive Results on Two Year Study for the Remediation of Potash Brine-Impacted Groundwater
6. East LA Pediatric Dentist, Dr. Ramin Assili, Comments on the Study on Crooked Bites and What They Indicate
7. Study Shows Improper EHR Medical Coding Cause Inaccurate Medical Bills and Lost Revenue; EHR Shortcuts to Blame
8. Induced Pluripotent Stem Cells Combo Could Yield Much-needed Models to Study Vascular Disease
9. Author Del Hermosura’s Newly Released “Treasure The Treasure” Offers a Fun and Effective Way to Study the Bible
10. Bcureful Donates $30,000 to Fund Telemedicine and TSC Research Study
11. Study Shows Beautiful Smile Provides High Self-Esteem and Success—CDA Leads the Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: